Stocks · Health care · Biological Products, (No Diagnostic Substances)

Adaptive Biotechnologies Corp

ADPT Clue Score46
United States Fiscal year ends December CIK 0001478320 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Kyle Piskel
14 Mar 2025
Chief Financial Officer
Exercised, kept
2,500
$6.32
$15.80K
Susan Bobulsky
8 Oct 2024
Chief Commercial Officer, MRD
Exercised, kept
5,000
$1.98
$9.90K
Peter M Neupert
12 Mar 2024
Director
Exercised, kept
15,000
$0.84
$12.60K
Peter M Neupert
13 Dec 2023
Director
Exercised, kept
100,000
$0.84
$84.00K
Robert Hershberg
2 Feb 2023
Director
Exercised, kept
53,000
$0.45
$23.85K
Showing 250 of 978 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 495
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 42
Sales straight out of an exercise 765
Sales at will 156
Transactions with no price 0
Shares from compensation/vesting 115,989,153
Sales filed before the plan box existed 107
History held since 2 Jul 2019